X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Newspaper Article (29528) 29528
Journal Article (27593) 27593
Newsletter (14192) 14192
Magazine Article (1836) 1836
Government Document (1387) 1387
Book / eBook (413) 413
Transcript (400) 400
Web Resource (300) 300
Trade Publication Article (278) 278
Book Review (180) 180
Book Chapter (176) 176
Dissertation (160) 160
Reference (152) 152
Patent (151) 151
Report (105) 105
Paper (100) 100
Conference Proceeding (43) 43
Streaming Video (28) 28
Archival Material (10) 10
Publication (9) 9
Journal / eJournal (8) 8
Video Recording (3) 3
Data Set (1) 1
Pamphlet (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aids (28050) 28050
aids vaccines (21087) 21087
acquired immune deficiency syndrome--aids (20632) 20632
hiv (20556) 20556
humans (16863) 16863
human immunodeficiency virus--hiv (15540) 15540
vaccines (15377) 15377
research (12523) 12523
medical research (12103) 12103
infectious diseases (7818) 7818
medicine, experimental (7772) 7772
immunology (7636) 7636
health aspects (7550) 7550
female (6548) 6548
animals (6027) 6027
acquired immune deficiency syndrome (5860) 5860
male (5604) 5604
infections (5409) 5409
infection (5144) 5144
prevention (5109) 5109
hiv infection (4820) 4820
public health (4754) 4754
virology (4734) 4734
viruses (4574) 4574
adult (4444) 4444
hiv infections - prevention & control (4350) 4350
aids vaccines - immunology (4309) 4309
hiv-1 - immunology (4094) 4094
hiv infections - immunology (4003) 4003
human immunodeficiency virus (3997) 3997
research & development--r&d (3735) 3735
vaccination (3714) 3714
coronaviruses (3659) 3659
clinical trials (3549) 3549
immunization (3545) 3545
covid-19 (3466) 3466
analysis (3375) 3375
bacteria (3267) 3267
medicine (3256) 3256
drug therapy (3188) 3188
virus diseases (3138) 3138
pandemics (3026) 3026
research article (2746) 2746
studies (2743) 2743
disease transmission (2697) 2697
multidisciplinary sciences (2680) 2680
t cells (2653) 2653
pharmaceutical industry (2573) 2573
middle aged (2519) 2519
human-immunodeficiency-virus (2421) 2421
antibodies (2415) 2415
care and treatment (2412) 2412
risk factors (2339) 2339
antiviral agents (2326) 2326
microbiology (2317) 2317
epidemics (2313) 2313
immune system (2290) 2290
coronavirus aid relief & economic security act 2020-us (2232) 2232
epidemiology (2204) 2204
drugs (2199) 2199
aids/hiv (2166) 2166
humanitarian aid (2162) 2162
tuberculosis (2138) 2138
cancer (2119) 2119
science (2118) 2118
antigens (2101) 2101
proteins (2065) 2065
mice (2049) 2049
hiv infections - virology (2048) 2048
hiv-1 - genetics (2034) 2034
hiv-1 (2019) 2019
adolescent (2011) 2011
hiv infections - epidemiology (1855) 1855
medicine, research & experimental (1815) 1815
immune response (1808) 1808
hiv infections - drug therapy (1804) 1804
lymphocytes (1768) 1768
vaccine (1752) 1752
hiv/aids (1748) 1748
disease (1702) 1702
universities and colleges (1657) 1657
public, environmental & occupational health (1620) 1620
hiv testing (1582) 1582
young adult (1579) 1579
antiretroviral therapy (1571) 1571
hiv patients (1561) 1561
aids vaccines - administration & dosage (1559) 1559
product development (1551) 1551
viral load (1535) 1535
sexually transmitted diseases (1534) 1534
immunodeficiency-virus type-1 (1522) 1522
physiological aspects (1519) 1519
highly active antiretroviral therapy (1507) 1507
mortality (1506) 1506
medicine, general & internal (1482) 1482
antiretroviral drugs (1438) 1438
biology (1435) 1435
women (1423) 1423
children (1359) 1359
molecular sequence data (1344) 1344
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (164) 164
Online Resources - Online (53) 53
Collection Dvlpm't (Acquisitions) - Vendor file (43) 43
UofT at Scarborough - Stacks (34) 34
Robarts - Stacks (18) 18
UofT at Mississauga - Stacks (17) 17
New College (Ivey) - Stacks (16) 16
Collection Dvlpm't (Acquisitions) - Closed Orders (12) 12
Trinity College (John W Graham) - Stacks (10) 10
University College (Laidlaw) - Stacks (6) 6
Gerstein Science - Missing (4) 4
Law (Bora Laskin) - Stacks (4) 4
Victoria University E.J. Pratt - Stacks (4) 4
Media Commons - Audio Visual (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
Gerstein Science - Circulation Desk (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Media Commons - Microtexts (2) 2
St. Augustine's Seminary - Stacks (2) 2
St. Michael's Hospital - Stacks (2) 2
Thomas Fisher Rare Book - Rare Book (2) 2
UTL at Downsview - May be requested (2) 2
Credit Valley Hospital - Stacks (1) 1
Criminology - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Not Returned (1) 1
Gerstein Science - Periodical Stacks (1) 1
Gerstein Science - Searching (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Knox College (Caven) - Stacks (1) 1
Law (Bora Laskin) - Theses (1) 1
New College (Ivey) - Missing (1) 1
New College (Ivey) - Reserve desk (1) 1
OISE - Theses (1) 1
Regis College - Stacks (1) 1
Robarts - Government Pubs (1) 1
St. Michael's Hospital - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
UofT Schools - Stacks (1) 1
UofT at Scarborough - Circulation Desk (1) 1
UofT at Scarborough - Not Returned (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (76427) 76427
French (239) 239
German (123) 123
Spanish (105) 105
Portuguese (82) 82
Japanese (73) 73
Chinese (66) 66
Russian (38) 38
Italian (17) 17
Polish (16) 16
Swedish (8) 8
Danish (7) 7
Norwegian (7) 7
Czech (5) 5
Hebrew (4) 4
Persian (4) 4
Turkish (4) 4
Arabic (3) 3
Bulgarian (3) 3
Dutch (3) 3
Hindi (3) 3
Lithuanian (3) 3
Romanian (3) 3
Urdu (3) 3
Afrikaans (2) 2
Finnish (2) 2
Korean (2) 2
Croatian (1) 1
Estonian (1) 1
Greek (1) 1
Hungarian (1) 1
Icelandic (1) 1
Indonesian (1) 1
Latvian (1) 1
Serbian (1) 1
Slovenian (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2015, ISBN 0199334412, x, 559 p., 16 unnumbered p.s of plates
"He first full biography of Jonas Salk offers a complete picture of the enigmatic figure, from his early years working on an influenza vaccine--for which he never fully got credit--to his seminal... 
Influenza vaccines | MEDICAL / History | AIDS vaccines | SCIENCE / History | Poliomyelitis | United States | Poliomyelitis vaccine | Vaccination | MEDICAL / Diseases | Salk, Jonas, 1914-1995 | Virologists | History
Book
PloS one, ISSN 1932-6203, 2018, Volume 13, Issue 11, p. e0206838
Background We evaluated the safety and immunogenicity of (i) an intradermal HIV-DNA regimen given with/without intradermal electroporation (EP) as prime and... 
HUMORAL IMMUNE-RESPONSES | ELECTROPORATION | DNA VACCINE | SAFETY | MULTIDISCIPLINARY SCIENCES | BROAD | TYPE-1 | HIV Antibodies - blood | Immunogenicity, Vaccine | HIV Infections - prevention & control | Vaccines, DNA - genetics | env Gene Products, Human Immunodeficiency Virus - immunology | Humans | Viral Vaccines - genetics | AIDS Vaccines - immunology | Vaccines, DNA - immunology | Glucosides - immunology | Male | Administration, Cutaneous | Healthy Volunteers | Viral Vaccines - adverse effects | Vaccines, DNA - administration & dosage | AIDS Vaccines - adverse effects | Vaccinia virus - immunology | Young Adult | Antibodies, Neutralizing - immunology | env Gene Products, Human Immunodeficiency Virus - genetics | Lipid A - immunology | Mozambique | Vaccination - methods | HIV Antibodies - immunology | Adult | Female | Tanzania | Electroporation | Immunization, Secondary - methods | Viral Vaccines - administration & dosage | HIV-1 - immunology | Vaccines, DNA - adverse effects | AIDS Vaccines - genetics | AIDS Vaccines - administration & dosage | Viral Vaccines - immunology | Antibodies, Neutralizing - blood | AIDS vaccines | Usage | Care and treatment | Adults | Health aspects | HIV infection | Risk factors | Laboratories | Vaccination | Clinical trials | Viruses | Lipids | Infections | DNA vaccines | Vaccines | Lipid A | Proteins | Randomization | Immunology | Gag protein | Acquired immune deficiency syndrome--AIDS | Audio frequencies | Safety engineering | Human immunodeficiency virus--HIV | Safety | Public health | Deoxyribonucleic acid--DNA | Enzyme-linked immunosorbent assay | Antigens | Medical research | Immunization | Immunoglobulins | Internal medicine | Envelope protein | Priming | Medicine | Glycoprotein gp160 | Hospitals | Infectious diseases | Immunogenicity | γ-Interferon | Glycoprotein gp120 | Acquired immune deficiency syndrome | Deoxyribonucleic acid | AIDS | HIV | DNA | Human immunodeficiency virus
Journal Article
Vaccine, ISSN 0264-410X, 2011, Volume 29, Issue 46, pp. 8417 - 8428
Highlights ► A phase I/II HIV vaccine trial has been conducted in Tanzania employing priming with HIV-1 DNA and boosting HIV-1 MVA... 
Allergy and Immunology | MVA boost | DNA prime | HIV vaccine | MEDICINE, RESEARCH & EXPERIMENTAL | VACCINIA VIRUS ANKARA | PHASE-1 SAFETY | IMMUNOGENICITY EVALUATION | CLADE-C | IMMUNOLOGY | DAR-ES-SALAAM | T-CELL RESPONSES | DOUBLE-BLIND | SMALLPOX VACCINATION | CANDIDATE VACCINE | MONOCLONAL-ANTIBODIES | Vaccines, DNA - genetics | Cell Proliferation | Humans | Viral Vaccines - genetics | AIDS Vaccines - immunology | Vaccines, DNA - immunology | Male | Neutralization Tests | Vaccines, Synthetic - immunology | Human Experimentation | Vaccines, DNA - administration & dosage | Vaccinia virus - genetics | Drug Carriers | Young Adult | Acquired Immunodeficiency Syndrome - immunology | Vaccination - methods | Leukocytes, Mononuclear - immunology | Adult | Female | Acquired Immunodeficiency Syndrome - virology | Placebos - administration & dosage | Injections, Intradermal | Interferon-gamma - secretion | Vaccines, Synthetic - genetics | Tanzania | Acquired Immunodeficiency Syndrome - prevention & control | Viral Proteins - genetics | Immunization, Secondary - methods | Enzyme-Linked Immunospot Assay | HIV-1 - genetics | Viral Vaccines - administration & dosage | HIV-1 - immunology | Plasmids | Adolescent | AIDS Vaccines - genetics | Vaccines, Synthetic - administration & dosage | AIDS Vaccines - administration & dosage | Genetic Vectors | Viral Vaccines - immunology | Interferon-gamma - biosynthesis | Viral antibodies | AIDS vaccines | Immune response | DNA | Vaccination | Antibodies | Universities and colleges | HIV (Viruses) | Biometry | Vaccines | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Immunization | CD8 antigen | Immune response (cell-mediated) | DNA vaccines | Lymphocytes T | Corticotropin-releasing hormone | CD4 antigen | glycoprotein gp160 | Gag protein | Immunogenicity | Interleukin 2 | Lymphocytes | Peripheral blood mononuclear cells | Serological tests | Enzyme-linked immunosorbent assay
Journal Article
Vaccine, ISSN 0264-410X, 2008, Volume 26, Issue 35, pp. 4477 - 4485
.... The balance between tolerance and immunogenicity remains the main concern in the proof of concept of plant-based vaccine. 
Allergy and Immunology | HIV-1 | Tolerance | VLPs | Vaccine | HBV | Transgenic plants | MEDICINE, RESEARCH & EXPERIMENTAL | transgenic plants | DENDRITIC CELLS | IMMUNODEFICIENCY-VIRUS | GASTROINTESTINAL-TRACT | CD4(+) T-CELLS | B SURFACE-ANTIGEN | IMMUNOLOGY | vaccine | IMMUNE-RESPONSES | VIRUS-LIKE PARTICLES | INFECTION | HEPATITIS-B | tolerance | Vaccines, Edible - administration & dosage | AIDS Vaccines - immunology | Vaccines, DNA - immunology | AIDS Vaccines - adverse effects | Lymphocyte Subsets - immunology | T-Lymphocytes, Regulatory - immunology | Epitopes - immunology | Flow Cytometry | Vaccines, Virosome - immunology | Plants, Genetically Modified | Female | Viral Proteins - biosynthesis | Administration, Oral | Lymphocyte Activation | Vaccines, Virosome - administration & dosage | Hepatitis B Vaccines - administration & dosage | Viral Proteins - genetics | Immunization, Secondary - methods | Lymph Nodes - immunology | Epitopes - genetics | HIV-1 - genetics | Tobacco | Animals | Vaccines, Edible - adverse effects | Vaccines, Edible - immunology | Hepatitis B Vaccines - adverse effects | Vaccines, Virosome - adverse effects | Hepatitis B virus - genetics | Hepatitis B Vaccines - immunology | Mice | AIDS Vaccines - administration & dosage | CD8-Positive T-Lymphocytes - immunology | Biological products industry | Genetic engineering | Plants | Vaccines | HIV (Viruses) | T cells | Hepatitis B | Proteins | Metabolites | Lymphocytes | Human immunodeficiency virus--HIV | Rodents | Infections | Flowers & plants | Viral infections | Immune system | Vaccines, DNA | Viral Proteins | CD8-Positive T-Lymphocytes | Life Sciences | Immunization, Secondary | Immunology | T-Lymphocytes, Regulatory | Vaccines, Edible | Hepatitis B virus | Vaccines, Virosome | Epitopes | Lymph Nodes | Vaccinology | Lymphocyte Subsets | Hepatitis B Vaccines | AIDS Vaccines
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 51, pp. 7344 - 7351
Abstract Recombinant adenoviral vector (rAd)-based vaccines are currently being developed for several infectious diseases and cancer therapy, but pre-existing seroprevalence to such vectors may prevent their use in broad human populations... 
Allergy and Immunology | Adenoviral vectors | Vaccine development | Humoral immune response | Simian adenovirus | Chimpanzee adenovirus | Cellular immune response | NONHUMAN-PRIMATES | MEDICINE, RESEARCH & EXPERIMENTAL | V3 LOOP | NEUTRALIZING ANTIBODIES | DENDRITIC CELLS | RHESUS-MONKEYS | ENVELOPE GLYCOPROTEIN | IMMUNOLOGY | IMMUNIZATION | T-CELL RESPONSES | IMMUNE-RESPONSES | GENE-TRANSFER | Vaccines, DNA - genetics | Adenoviruses, Simian - immunology | AIDS Vaccines - isolation & purification | Immunoglobulin G - blood | Viral Vaccines - genetics | AIDS Vaccines - immunology | Vaccines, DNA - immunology | Drug Discovery - methods | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Drug Carriers | Vaccines, Synthetic - isolation & purification | Adenoviruses, Simian - genetics | CD4-Positive T-Lymphocytes - immunology | Viral Vaccines - isolation & purification | Female | Vaccines, DNA - isolation & purification | SAIDS Vaccines - isolation & purification | Vaccines, Synthetic - genetics | SAIDS Vaccines - genetics | Animals | SAIDS Vaccines - immunology | AIDS Vaccines - genetics | Mice, Inbred BALB C | CD8-Positive T-Lymphocytes - immunology | Genetic Vectors | Viral Vaccines - immunology | Monkeys | Vaccines | T cells | Health aspects | Immunotherapy | Immunoglobulin G | Antigens | Medical research | AIDS vaccines | Immune response | Communicable diseases | Adenoviruses | Medicine, Experimental | Development and progression | Studies | Ebola virus | Patents | Immunoglobulins | Inventors | Clinical trials | Viruses | Monkeys & apes | Vectors (Biology) | Deoxyribonucleic acid--DNA
Journal Article
Vaccine, ISSN 0264-410X, 2013, Volume 31, Issue 48, pp. 5706 - 5712
Highlights • rHPIV3cp45 vaccine was immunogenic and well-tolerated in seronegative young children... 
Allergy and Immunology | Live-attenuated vaccine | Recombinant virus vaccine | Pediatric vaccine | Parainfluenza | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNOGENICITY | MUTANTS | INFANTS | PROGRESS | IMMUNOLOGY | RESPIRATORY SYNCYTIAL VIRUS | Humans | Parainfluenza Vaccines - adverse effects | Child, Preschool | Infant | Male | Vaccination - adverse effects | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Respirovirus Infections - virology | Drug-Related Side Effects and Adverse Reactions - pathology | Parainfluenza Virus 3, Human - genetics | Vaccination - methods | Vaccines, Synthetic - adverse effects | Vaccines, Attenuated - administration & dosage | Female | Nasal Cavity - virology | Placebos - administration & dosage | Double-Blind Method | Vaccines, Synthetic - genetics | Parainfluenza Virus 3, Human - immunology | Parainfluenza Vaccines - genetics | Parainfluenza Vaccines - immunology | Respirovirus Infections - prevention & control | Drug-Related Side Effects and Adverse Reactions - epidemiology | Parainfluenza Vaccines - administration & dosage | Vaccines, Attenuated - immunology | Vaccines, Synthetic - administration & dosage | Vaccines, Attenuated - adverse effects | Vaccines, Attenuated - genetics | Virus diseases | AIDS vaccines | Safety and security measures | Children | Health aspects | Public health | Pediatrics | Hospitals | Illnesses | Respiratory diseases | Clinical trials | Ear diseases | Infections | Hospitalization | Vaccines | Age | Children & youth
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 7/2014, Volume 210, Issue 1, pp. 99 - 110
Background. Clade B DNA and recombinant modified vaccinia Ankara (MVA) vaccines producing virus-like particles displaying trimeric membrane-bound envelope giycoprotein (Env... 
T lymphocytes | HIV/AIDS | AIDS vaccines | HIV infections | HIV | Cytokines | Antibodies | Durability | AIDS | DNA vaccines | HIV 1 | DNA | Recombinant MVA | Clinical trial | Vaccines | T cells | clinical trial | VIRAL LOAD | INFECTIOUS DISEASES | vaccines | NEUTRALIZING ANTIBODY | MICROBIOLOGY | ENVELOPE PROTEIN | IMMUNOLOGY | T-CELL RESPONSES | EFFICACY TRIAL | NONNEUTRALIZING ANTIBODIES | DOUBLE-BLIND | antibodies | recombinant MVA | CONSERVED REGIONS | DNA/MVA VACCINE | INNATE IMMUNITY | HIV Antibodies - blood | env Gene Products, Human Immunodeficiency Virus - immunology | Humans | Middle Aged | AIDS Vaccines - immunology | Male | Vaccines, Synthetic - immunology | Vaccinia virus - genetics | Drug Carriers | Young Adult | Vaccines, Virus-Like Particle - genetics | env Gene Products, Human Immunodeficiency Virus - genetics | Time Factors | Adult | Female | Placebos - administration & dosage | Vaccines, Synthetic - genetics | HIV-1 - genetics | HIV-1 - immunology | Vaccines, Virus-Like Particle - administration & dosage | Adolescent | AIDS Vaccines - genetics | T-Lymphocytes - immunology | Vaccines, Virus-Like Particle - immunology | Vaccines, Synthetic - administration & dosage | AIDS Vaccines - administration & dosage | Usage | Immune response | Clinical trials | Genetic aspects | Research | HIV (Viruses) | Major and Brief Reports
Journal Article
Cold Spring Harbor Perspectives in Biology, ISSN 1943-0264, 09/2018, Volume 10, Issue 9
Journal Article